Immediate Discontinuation of Sliding-Scale Insulin and Transition to Scheduled Basal-Bolus Therapy
This 70-year-old nursing home resident with glucose ranging 70–500 mg/dL on a reactive sliding-scale regimen requires immediate conversion to a scheduled basal-bolus insulin approach, because sliding-scale insulin as monotherapy is explicitly condemned by all major diabetes guidelines and achieves target glucose in only ~38% of patients versus ~68% with basal-bolus therapy. 12
Critical Problems with the Current Regimen
- Sliding-scale insulin treats hyperglycemia only after it occurs, producing dangerous glucose fluctuations that worsen both hyper- and hypoglycemia rather than preventing them. 12
- The current approach—Lantus 12 U "if glucose >200 mg/dL" and Humalog 6 U twice daily "if glucose >200 mg/dL"—is not a true basal-bolus regimen but rather a reactive correction-only strategy that provides no scheduled basal coverage and no scheduled prandial insulin. 13
- No basal insulin is suppressing hepatic glucose production overnight or between meals, leading to persistent fasting hyperglycemia (glucose up to 500 mg/dL). 12
- Absence of scheduled prandial insulin causes post-prandial spikes that are later corrected with large reactive doses, creating a cycle of hyperglycemia → large correction → hypoglycemia (glucose 70 mg/dL) → rebound hyperglycemia. 12
- In nursing home residents, nearly two-thirds of those with hypoglycemia also have hyperglycemia, and efforts to de-intensify must address both simultaneously by tailoring insulin timing and type. 4
- Hypoglycemia occurs in 26% of nursing home residents on sliding-scale insulin within 30 days, and the average fingerstick burden is ~4 checks per day. 5
Recommended Basal-Bolus Insulin Regimen
Step 1: Calculate Total Daily Insulin Dose (TDD)
- Review the average total insulin used over the past 5–7 days from the sliding-scale records (Lantus + Humalog doses). 1
- For a nursing home resident with wide glucose fluctuations (70–500 mg/dL), a reasonable starting TDD is 0.3–0.5 U/kg/day for severe hyperglycemia. 3
- If the patient weighs ~70 kg, this translates to 21–35 U/day total. 3
Step 2: Allocate Basal Insulin (50% of TDD)
- Give 50% of the TDD as scheduled basal insulin once daily (e.g., 11–18 U of insulin glargine). 13
- Administer Lantus at the same time every day (bedtime is traditional, but morning dosing may reduce early-morning hypoglycemia risk in elderly patients). 67
- Do NOT give basal insulin "if glucose >200 mg/dL"—it must be scheduled regardless of glucose level to suppress hepatic glucose output. 188
Step 3: Allocate Prandial Insulin (50% of TDD)
- Give the remaining 50% of TDD as scheduled rapid-acting insulin divided among three meals (e.g., 4–6 U Humalog before breakfast, lunch, and dinner). 13
- Administer Humalog 0–15 minutes before meals, not "if glucose >200 mg/dL." 3
- For nursing home residents with irregular dietary intake or cognitive decline, the AMDA guidelines suggest a simplified approach: "give 4 units of mealtime insulin if glucose >300 mg/dL" as a safety measure, but scheduled doses are still preferred. 1
Step 4: Add Correction Doses (Adjunct Only)
- Correction insulin must supplement—not replace—scheduled basal and prandial doses. 13
- Use a simplified correction scale: 2 U Humalog for pre-meal glucose >250 mg/dL and 4 U for glucose >350 mg/dL, given in addition to the scheduled prandial dose. 3
Titration Protocol
Basal Insulin (Lantus) Titration
- Increase Lantus by 2 U every 3 days if fasting glucose is 140–179 mg/dL. 7
- Increase Lantus by 4 U every 3 days if fasting glucose ≥180 mg/dL. 7
- Target fasting glucose: 80–130 mg/dL (or 90–150 mg/dL for elderly patients with complex health). 67
- If any glucose reading falls <70 mg/dL, reduce the current basal dose by 10–20% immediately. 37
- Stop basal escalation when the dose approaches 0.5 U/kg/day (~35 U for a 70-kg patient) without achieving targets; at this point, focus on intensifying prandial insulin to avoid "over-basalization." 37
Prandial Insulin (Humalog) Titration
- Increase each meal dose by 1–2 U every 3 days based on 2-hour post-prandial glucose readings. 3
- Target post-prandial glucose: <180 mg/dL. 3
- If hypoglycemia occurs after a meal, reduce that specific meal dose by 10–20%. 3
Monitoring Requirements
- Daily fasting glucose to guide basal insulin adjustments. 7
- Pre-meal glucose before each meal to calculate correction doses. 3
- 2-hour post-prandial glucose after meals to assess prandial adequacy. 3
- Bedtime glucose to evaluate overall daily pattern. 3
- For nursing home residents with poor oral intake or irregular eating, check glucose every 4–6 hours and use a basal-plus-correction regimen (basal insulin + correction doses only, no scheduled prandial). 3
Special Considerations for Nursing Home Residents
- Wide glucose fluctuations (70–500 mg/dL) indicate both inadequate basal coverage AND postprandial excursions, requiring both basal and prandial insulin. 14
- For residents with cognitive decline or irregular dietary intake, the AMDA guidelines recommend: "Use scheduled basal and mealtime insulin based on individual needs with the goal of avoiding hypoglycemia. May use a simple scale, such as 'give 4 units of mealtime insulin if glucose >300 mg/dL.' Keep patients hydrated, especially when glucose levels are high (e.g., >300 mg/dL)." 1
- Hypoglycemia (glucose 70 mg/dL) in this patient signals that the current reactive approach is causing dangerous swings; a scheduled regimen will provide more stable glucose control. 45
- Approximately 48% of nursing home residents on insulin have hyperglycemia ≥250 mg/dL alone, 7% have hypoglycemia <70 mg/dL alone, and 12% have both, underscoring the need for a balanced basal-bolus approach. 4
Hypoglycemia Management
- Treat any glucose <70 mg/dL immediately with 15 g of fast-acting carbohydrate (e.g., 4 glucose tablets or 4 oz juice), recheck in 15 minutes, and repeat if needed. 3
- If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% before the next administration. 37
- Never use rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 3
Expected Clinical Outcomes
- With a properly implemented basal-bolus regimen, ~68% of patients achieve mean glucose <140 mg/dL, compared with ~38% on sliding-scale alone. 12
- Basal-bolus therapy does NOT increase hypoglycemia incidence when titrated according to protocol, unlike inadequate sliding-scale regimens. 12
- Glucose fluctuations will stabilize within 3–7 days after transitioning to scheduled insulin. 3
Common Pitfalls to Avoid
- Do NOT continue sliding-scale insulin as the sole regimen when glucose repeatedly exceeds 180 mg/dL or drops to 70 mg/dL; it is inferior and unsafe. 12
- Do NOT give Lantus or Humalog "if glucose >200 mg/dL"—both must be scheduled regardless of glucose level. 188
- Do NOT delay adding prandial insulin when basal insulin alone fails to control daytime glucose. 3
- Do NOT rely solely on correction doses without adjusting scheduled basal and prandial insulin; this perpetuates inadequate control. 13
Summary Algorithm
- Calculate average total daily insulin from past 5–7 days (or start with 0.3–0.5 U/kg/day for severe hyperglycemia). 13
- Give 50% as scheduled basal insulin (Lantus) once daily at the same time every day. 1388
- Give 50% as scheduled prandial insulin (Humalog) divided among three meals, administered 0–15 minutes before eating. 13
- Add correction doses (2 U for glucose >250 mg/dL, 4 U for >350 mg/dL) in addition to scheduled prandial doses. 3
- Titrate basal insulin by 2–4 U every 3 days based on fasting glucose. 7
- Titrate prandial insulin by 1–2 U every 3 days based on post-prandial glucose. 3
- Monitor daily fasting, pre-meal, post-prandial, and bedtime glucose to guide adjustments. 37
- Treat hypoglycemia <70 mg/dL immediately and reduce the implicated insulin dose by 10–20%. 37